[1]张广平,谢华宁.从2018中国心衰诊疗指南看更新亮点[J].陕西中医药大学学报,2020,(01):040-42,61.[doi:10.13424/j.cnki.jsctcm.2020.01.011]
 Zhang Guangping,Xie Huaning.Update Highlights from 2018 China Heart Failure Diagnosis and Treatment Guide[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):040-42,61.[doi:10.13424/j.cnki.jsctcm.2020.01.011]
点击复制

从2018中国心衰诊疗指南看更新亮点()
分享到:

《陕西中医药大学学报》[ISSN: 2096-1340/CN: 61-1501/R]

卷:
期数:
2020年01期
页码:
040-42,61
栏目:
出版日期:
2020-01-30

文章信息/Info

Title:
Update Highlights from 2018 China Heart Failure Diagnosis and Treatment Guide
文章编号:
2096-1340(2020)01-0040-04
作者:
张广平谢华宁
陕西省中医医院,陕西 西安 710003
Author(s):
Zhang Guangping Xie Huaning
Department of Heart Disease of Shaanxi TCM Hospital, Xi’ an China, 710003
关键词:
心力衰竭指南亮点射血分数
Keywords:
heart failure the “ Guide” highlights Ejection Fraction ( EF)
分类号:
R2-09
DOI:
10.13424/j.cnki.jsctcm.2020.01.011
文献标志码:
B
摘要:
2018年中国心衰指南具有“新、中、全、实”的特点,采用心衰新的分类及诊断标准,强调心衰要早筛、早诊加强预防,治疗采用新药,强调心衰综合管理等亮点,充分接轨国际,同时结合国内有代表性的临床循证医学证据,全面涵盖心衰发展的全程诊疗,为中国心衰诊疗标准化、规范化奠定了基础。新指南会让更多的医生运用最新的治疗理念、方法和手段进行规范化治疗,提高达标率,真正做到让患者获益。
Abstract:
2018 China Heart Failure Diagnosis and Treatment Guide features new, complete and authentic content with Chinese characteristic. It adopts new classification and diagnostic criteria for heart failure, and emphasizes the early screening, early diagnosis and strengthened prevention. New drugs are used in the treatment, and comprehensive management of heart failure is also emphasized. The 2018 Heart Failure Diagnosis and Treatment Guide has many highlights, fully geared to the international standards. Meanwhile, it combines domestic representative clinical evidence - based medical evidence to comprehensively cover the entire diagnosis and treatment of heart failure development, laying a foundation for the standardization of heart failure diagnosis and treatment in China. The new Guide( 2018 Heart Failure Diagnosis and Treatment Guide) will enable more doctors to use the latest treatment concepts, methods and means for standardized treatment, improve the rate of reaching the standard, and truly benefit patients.

参考文献/References:

[1]Brenyo A, Barsheshet A, Kutyifa V, et al. Predictors of spontaneous reverse remodeling in mild heart failure patients with left ventricular dysfunction [ J] . Circ Heart Fail, 2014, 7( 4) :565 -572.
[2] Braunwald E. The war against heart failure: the Lancet lecture. Lancet. Lancet 2015; 385: 812- 24.
[3] Dhalla N S, Rangi S, Babick A P, et al. Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging[ J] . Heart Fail Rev, 2012, 17( 4 -5) :671 -681.
[4] Dhalla N S, Saini H K, Tappia P S, et al. Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease[ J] . J Cardiovasc Med ( Hagerstown) , 2007, 8( 4) : 238 -250.
[5]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南 2018[J].中华心血管病杂志,2018,46(10):760-789.
[6]中华医学会心血管病分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南 2014[J].中华心血管病杂志,2014,42(2):98-122.
[7] Ksi czyk M, Lelonek M. Angiotensin eceptor/ neprilysin inhibitor - a breakthrough in chronic heart failure therapy:summary of subanalysis on PARADIGM - HF trial findings. Heart Fail Rev[ J] . 2019, [ Epub ahead of print].
[8]王永霞,朱明军.中医药防治慢性心力衰竭的研究思考[J].中华中医药杂志,2012,27(7):1868-1870.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局第三届国医大师/全国名中医传承工作室建设项目(国中医药办人教函(2018)119号)
更新日期/Last Update: 2020-01-15